Published in J Clin Oncol on August 01, 1992
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg (2004) 3.50
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer (2006) 1.39
Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer (2008) 0.90
Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. Ann Surg (1998) 0.88
Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc (2009) 0.87
Epithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer. Br J Cancer (2012) 0.85
Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy. Cancers (Basel) (2011) 0.83
Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior? World J Gastroenterol (2011) 0.83
Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers. World J Surg Oncol (2010) 0.81
Molecular prognostic prediction for locally advanced nasopharyngeal carcinoma by support vector machine integrated approach. PLoS One (2012) 0.81
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Med Genomics (2014) 0.79
In rectal carcinoma, colostomy or no colostomy: is this the question? J Clin Oncol (1993) 0.79
Multidisciplinary case teams: an approach to the future management of advanced colorectal cancer. Br J Cancer (1998) 0.78
What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer. Radiat Oncol (2013) 0.78
Histologic response after neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma: experience from Sudan. Afr Health Sci (2016) 0.77
Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancer. World J Gastrointest Oncol (2012) 0.76
Chemotherapy of Colorectal Cancer. Curr Treat Options Gastroenterol (1999) 0.75
MTHFR C677T Polymorphism is Associated with Tumor Response to Preoperative Chemoradiotherapy: A Result Based on Previous Reports. Med Sci Monit (2015) 0.75
Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors. Radiat Oncol (2006) 0.75
Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis. Pharmacogenomics J (2016) 0.75
Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation. J Gastrointest Oncol (2016) 0.75
CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF-1α. Cancer Res (2016) 0.75
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63
Response to editorial in Neurourol Urodynam 17(2). Government's role in health care. Neurourol Urodyn (1998) 5.03
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med (1981) 4.90
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25
Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA (2000) 3.18
Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum (2004) 3.12
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer (1999) 3.06
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol (1991) 2.94
Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation. Int J Radiat Oncol Biol Phys (1996) 2.76
Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60
Reduced cerebral embolic signals in beating heart coronary surgery detected by transcranial Doppler ultrasound. Br J Anaesth (2000) 2.56
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer (1999) 2.49
Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res (1994) 2.46
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs (1994) 2.33
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol (1992) 2.31
Signal detection and noise suppression using a wavelet transform signal processor: application to ultrasonic flaw detection. IEEE Trans Ultrason Ferroelectr Freq Control (1997) 2.26
Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer (1984) 2.26
Chemotherapy for colorectal carcinoma: one small step forward, one step backward. J Clin Oncol (1995) 2.16
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med (1987) 2.15
Mutations affecting cell division in Tetrahymena pyriformis. I. Selection and genetic analysis. Genetics (1976) 1.97
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med (1981) 1.97
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma. J Clin Oncol (1991) 1.94
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst (1996) 1.93
Clinical findings associated with acute proximal deep vein thrombosis: a basis for quantifying clinical judgment. Am J Med (1990) 1.93
Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol (1999) 1.92
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. Br J Cancer (2011) 1.90
Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res (1990) 1.90
Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer (1983) 1.87
Anatomical basis of autonomic nerve-preserving total mesorectal excision for rectal cancer. Br J Surg (1996) 1.85
Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg (1999) 1.84
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol (1999) 1.84
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol (2001) 1.83
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol (1998) 1.80
Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer (1992) 1.78
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer (2004) 1.75
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol (1985) 1.72
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys (2000) 1.71
The effect of nucleic acid antagonists on cell division and oral organelle development in Tetrahymena pyriformis. J Exp Zool (1965) 1.70
Secretion of collagen by embryonic neuroepithelium at the time of spinal cord--somite interaction. Dev Biol (1971) 1.69
Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol (1999) 1.68
Health-related quality of life among children and adolescents: associations with obesity. Int J Obes (Lond) (2006) 1.67
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol (1986) 1.63
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst (1994) 1.63
Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants. J Pediatr (1997) 1.62
Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg (1994) 1.61
The operative treatment of Crohn's disease complicated by fistulae. A personal consecutive series. Arch Surg (1969) 1.59
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. Ann Oncol (2012) 1.55
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. J Clin Oncol (1992) 1.54
Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg (1996) 1.52
In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A (1987) 1.50
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci U S A (1995) 1.47
Early discharge after modified radical mastectomy. Am J Surg (1986) 1.47
Diet, fat accretion, and growth in premature infants. N Engl J Med (1981) 1.45
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst (2000) 1.45
Lenticulostriate vasculopathy in infants with infections of the central nervous system sonographic and Doppler findings. Pediatr Radiol (1990) 1.45
Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer (1992) 1.45
Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol (1999) 1.44
Urinary diversion after total pelvic exenteration for rectal cancer. Ann Surg Oncol (1999) 1.44
Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma: a comparative study to surgical resection. Cancer (1980) 1.42
Meningioma--an unrecognised complication of fibrous dysplasia of the skull? J Neurol Neurosurg Psychiatry (1989) 1.42
Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg (1979) 1.42
A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma. Cancer J (2001) 1.41
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg (1999) 1.41
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis (1999) 1.41
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum (1997) 1.41
Failure patterns following curative resection of colonic carcinoma. Ann Surg (1984) 1.39
Adjuvant external beam and intraoperative radiation therapy in rectal cancer. Cancer Invest (1989) 1.39
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol (2009) 1.39
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol (1996) 1.39
Fetal intracranial haemorrhage: clinical significance of in utero ultrasonographic diagnosis. Br J Obstet Gynaecol (1993) 1.38
Local surgical treatment of rectal cancer. Cancer Invest (1995) 1.38
Significance and treatment of occult obstructive uropathy complicating Crohn's disease. Ann Surg (1973) 1.38
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol (2007) 1.38
Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg (1984) 1.38
Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg (1997) 1.38
Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol (1984) 1.35
Carcinoma developing in ileostomies after 25 or more years. Gastroenterology (1988) 1.34
Form and pattern in ciliated protozoa: analysis of a genic mutant with altered cell shape in Tetrahymena pyriformis, Syngen 1. J Exp Zool (1975) 1.34
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Ann Oncol (2007) 1.33
Chemotherapy in esophageal cancer. Semin Oncol (1999) 1.33
Randomized management of the second nonvertex twin: vaginal delivery or cesarean section. Am J Obstet Gynecol (1987) 1.32